Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC ...

The North American market accounted for nearly 50% of that revenue last year, led by the U.S. Four new surgical robots have been introduced this year and major medical technology companies like ...

A team at the University of Virginia has developed a monoclonal antibody to stop sepsis, the leading cause of death in U.S. hospitals.

More than two years after the Food and Drug Administration held a public workshop on measuring overall survival (OS) in ...

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

After years of striking acquisitions to build up its site network, Headlands Research has now been bought itself.  | After ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

Dr. Hussein Tawbi, who works for MD Anderson in Houston, said there are two things he hopes people take away from the story ...

Dr. Miller said he was optimistic that the clinical trial results would support an F.D.A. approval, but if or when that might happen is unclear, especially given recent changes at the agency.